Three-Year Clinical Follow-Up of the Unrestricted Use of Sirolimus-Eluting Stents as Part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) Registry
- 1 October 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 98 (7) , 895-901
- https://doi.org/10.1016/j.amjcard.2006.04.031
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phaseAmerican Heart Journal, 2006
- Sirolimus-Eluting Stents Remain Superior to Bare-Metal Stents at Two YearsJournal of the American College of Cardiology, 2006
- Evaluation of Four-Year Coronary Artery Response After Sirolimus-Eluting Stent Implantation Using Serial Quantitative Intravascular Ultrasound and Computer-Assisted Grayscale Value Analysis for Plaque Composition in Event-Free PatientsJournal of the American College of Cardiology, 2005
- The Coronary ArteryRevascularisation in Diabetes (CARDia) trial: Background, aims, and designAmerican Heart Journal, 2005
- Impact of Sirolimus-Eluting Stents on Outcome in Diabetic PatientsCirculation, 2004
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004
- Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”Circulation, 2004
- Stent fracture and restenosis in the drug‐eluting stent eraCatheterization and Cardiovascular Interventions, 2003
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Sirolimus-Eluting Stent for the Treatment of In-Stent RestenosisCirculation, 2003